Small marks on the DNA and histones regulate our genes, but they can also trigger cancer. Taking new approaches to find ways to reverse these changes might be a new therapeutic approach to tackle these malignant cancers.   Bayer researchers are working on active ingredients that can turn tumour cells back into healthy ones.

To find out more click here: https://www.research.bayer.com/en/tumor-cells-switch-off-epigenetics.aspx